IFNA4 and neoplasm: When compared to B16.GFP.gB.luc control tumors, we observed a reduction in type 2 inflammatory cells in B16.IFNα4.gB.luc tumors, most notably ILC2s, tumor-associated macrophages (TAMs) and fibroblasts (Fig. 2, E and F).